Saint Charles, MONCT06672952Now EnrollingIRB Ready

Exercise Performance Clinical Trial in Saint Charles, MO

Access cutting-edge exercise performance treatment through this clinical trial at a research site in Saint Charles. Study-provided care at no cost to qualified participants.

Sponsored by Lindenwood University

Quick Self-Assessment

See if you qualify for this Saint Charles location

Preparing your pre-screening questions…

Expert Care in Saint Charles

Access exercise performance specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related exercise performance treatment provided free

Apply for This Saint Charles Location

Check if you qualify for this exercise performance clinical trial in Saint Charles, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Saint Charles

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Saint Charles site if eligible
  4. 4Begin participation

About This Exercise Performance Study in Saint Charles

The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.

Sponsor: Lindenwood University

Who Can Participate

Inclusion Criteria

Participants who are between 18 - 50 years of age
Body mass index values will range from \>25.0 \< 30.0 kg/m2
The average body mass index for entire study cohort will be less than 27.0 kg/m2. As such an ongoing calculation of the recruited cohort's mean body mass index will be maintained and people will only be randomized into the study if the average cohort body mass index value does not exceed 27.0 kg/m2
Free-living and independent
In good health absent of being overweight or mildly obese with no other signs or symptoms of cardiovascular, respiratory, metabolic, immune, psychiatric, or musculoskeletal disease or disorders
Willingness to maintain consistent sleep duration the evening before study visits
Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, and carry out all study-related procedures
Regular completion of at least 180 minutes of moderate to vigorous exercise per week for the past 6 months

Exclusion Criteria

Not currently completing at least 180 minutes of moderate to vigorous exercise per week for the past 6 months
Positive medical history and/or is currently being treated for some form of heart disease, cardiovascular disease
Currently being treated for kidney disease, renal failure, or has dialysis performed on regular intervals
Has liver disease or some form of clinically diagnosed hepatic impairment
Diagnosed with having Type I or Type II diabetes (determined as fasting blood glucose \> 126 mg/dL)
Diagnosed with or is being treated for some form of thyroid disease
Diagnosed with major affective disorder or other psychiatric disorder that required hospitalization in the prior year
Diagnosed with some form of immune disorder (i.e., HIV/AIDS)
History of cancer (except localized skin cancer without metastases or in situ cervical cancer within 5 years prior to screening visit).
Participant has an abnormality or obstruction of the gastrointestinal tract precluding swallowing (e.g., dysphagia) and digestion (e.g., known intestinal malabsorption, celiac disease, inflammatory bowel disease, chronic pancreatitis, steatorrhea)
Positive medical history for any neurological condition or neurological disease
Currently prescribed a statin drugs (i.e., Lipitor, Livalo, Crestor, Zocor, etc.) or any hypertension medications (i.e., Beta-blockers, ACE Inhibitors, Alpha blockers, Vasodilators, etc.)
Current smoker (average of \> 1 pack per day within the past 3 months) has quit within the past six months. This includes all forms of nicotine
Intake of any drugs (prescribed or over the counter) or dietary supplements that are known or are purported to weight loss such as thermogenics, hydroxycitric acid, ephedra, capsaicin, etc.
Participants who are lactating, pregnant or planning to become pregnant
Have a known sensitivity or allergy to any of the study products
History of alcohol or substance abuse in the 12 months prior to screening
Receipt or use of an investigational product in another research study within 30 days of beginning the study protocol
Any orthopedic limitation that would prevent participation in a general fitness program
Any condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Saint Charles?

Yes, this clinical trial (NCT06672952) has an active research site in Saint Charles, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Exercise Performance Treatment Options in Saint Charles, MO

If you're searching for exercise performance treatment options in Saint Charles, MO, this clinical trial (NCT06672952) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Saint Charles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced exercise performance specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all exercise performance clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Saint Charles, MO

See all pulmonary embolism clinical trials recruiting in Saint Charles — not just this study.

Browse Pulmonary Embolism Trials in Saint Charles →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in Saint Charles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Saint Charles, MO